Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of December 2024, specifically dated December 13, 2024. The report serves as a notification of a transaction by a Person Closely Associated (PCA) with a Person Discharging Managerial Responsibility (PDMR), in compliance with Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not contain operational financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data provided relates to a specific share transaction:
- Transaction Type: Purchase of ordinary shares.
- Volume: 7,500,000 shares.
- Weighted Average Price: £4.134137 per share.
- Total Transaction Value: £31,006,028.
- Exchange: London Stock Exchange (XLON).
Material Changes
The material change reported is the acquisition of a significant block of shares by Trian Fund Management, L.P., a PCA of Non-Executive Director Brian Baldwin. This transaction occurred on December 11, 2024. No other material changes to the company's financial position or operations are disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. The document is strictly a regulatory disclosure of a director-related share purchase.
Investor Verification Checklist
- Verify the current total shareholding percentage of Trian Fund Management, L.P. following this purchase.
- Confirm the relationship between Trian Fund Management, L.P. and Non-Executive Director Brian Baldwin.
- Check the prevailing market price of Rentokil Initial plc shares on December 11, 2024, to compare against the weighted average purchase price of £4.134137.
- Review subsequent filings to determine if this purchase triggers any additional disclosure thresholds under UK or US regulations.